Literature DB >> 24575818

Editorial. Themed issue of the British Journal of Pharmacology.

R J Summers1.   

Abstract

This themed issue of the British Journal of Pharmacology stems from the 7th in the series of meetings on the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) held at the Monash Institute of Pharmaceutical Sciences in Melbourne Australia from the 6th-8th December 2012.
© 2014 The British Pharmacological Society.

Keywords:  GPCRs; anti-diabetic drugs < B. mediators; anti-inflammatory drugs; anticancer drugs; apoptosis < D. functional systems GPCRs; channels & ligands; drug receptor mechanisms; endocrine pharmacology; gastrointestinal pharmacology; molecular pharmacology < A. general fields; neuropharmacology < C. drug classes; other neuropeptides; receptors; transporters

Mesh：

Substances：

Year:  2014        PMID： 24575818      PMCID： PMC3952788          DOI： 10.1111/bph.12587

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  12 in total

Review 1.  Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.

Authors:  M D Hollenberg; K Mihara; D Polley; J Y Suen; A Han; D P Fairlie; R Ramachandran
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 2.  The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs.

Authors:  Andrea J Vernall; Stephen J Hill; Barrie Kellam
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Structure of class B GPCR corticotropin-releasing factor receptor 1.

Authors:  Kaspar Hollenstein; James Kean; Andrea Bortolato; Robert K Y Cheng; Andrew S Doré; Ali Jazayeri; Robert M Cooke; Malcolm Weir; Fiona H Marshall
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

Review 4.  Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.

Authors:  M Dong; C Koole; D Wootten; P M Sexton; L J Miller
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 5.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 6.  GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation.

Authors:  T Lieu; G Jayaweera; N W Bunnett
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 7.  Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.

Authors:  K Pabreja; M A Mohd; C Koole; D Wootten; S G B Furness
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

8.  Structure of the human glucagon class B G-protein-coupled receptor.

Authors:  Fai Yiu Siu; Min He; Chris de Graaf; Gye Won Han; Dehua Yang; Zhiyun Zhang; Caihong Zhou; Qingping Xu; Daniel Wacker; Jeremiah S Joseph; Wei Liu; Jesper Lau; Vadim Cherezov; Vsevolod Katritch; Ming-Wei Wang; Raymond C Stevens
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

Review 9.  WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3.

Authors:  J P Dijksterhuis; J Petersen; G Schulte
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 10.  The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.

Authors:  C Clemmensen; S Smajilovic; P Wellendorph; H Bräuner-Osborne
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.